Cell Cycle Regulation and Adult T Cell Leukemia

细胞周期调节和成人 T 细胞白血病

基本信息

  • 批准号:
    8607461
  • 负责人:
  • 金额:
    $ 29.87万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2010
  • 资助国家:
    美国
  • 起止时间:
    2010-04-01 至 2016-01-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): HTLV-I is the causative agent of adult T-cell leukemia/lymphoma (ATL), a malignancy of CD4+ T cells whose etiology is associated with the viral transactivator/oncoprotein, Tax. We have shown that Tax can activate the anaphase promoting complex/cyclosome (APC/C), an E3 ubiquitin ligase that controls metaphase to anaphase transition and mitotic exit. APC/C activation by Tax leads to the premature poly-ubiquitination and degradation of mitotic regulators including cyclin A, cyclin B, securin, and Skp2. Skp2 is the substrate-targeting subunit of another E3 ubiquitin ligase known as SCFSkp2, which mediates the destruction of cyclin E/A-CDK2 inhibitor (CKI), p27. The degradation of Skp2 by APC/C as induced by Tax leads to SCFSkp2 inactivation and p27 stabilization. The mRNA level of another CKI, p21, also increases sharply as a result of promoter activation and mRNA stabilization by Tax. The great surge in p21 and p27 in turn induces cellular senescence termed Tax-induced rapid senescence (Tax-IRS). As expected, HeLa and SupT1 T cells infected by HTLV-1 arrest in senescence as well. By contrast, cells deficient in p21 and p27, such as HOS, escape Tax-IRS and continue to divide after HTLV-1 infection or Tax expression. They, however, develop dramatic nuclear abnormalities in the form of multinucleation and DNA aneuploidy. Importantly, down-regulation of p27 and mis-localization of p21 are common in Tax-expressing HTLV-1-transformed T (HTxT) cells and most likely occur through activation of the PI3K- Akt pathway. Our latest results showed that Tax caused significant accumulation of the DNA replication licensing factor, Cdt1, during S/G2. In a most exciting recent development, we found that inhibition of NF-?B activation by Tax completely abrogated Tax-IRS. Our findings raise several important questions: How does persistent NF-?B activation lead to p21/p27 upregulation and senescence? Does NF-?B activation lie upstream of APC/C activation and Cdt1 accumulation? Does the accumulation of Cdt1 induced by Tax lead to DNA re/hyper-replication and can it explain the dramatic nuclear abnormalities seen in Tax-expressing cells? Finally, the senescence-like arrest induced by HTLV-1 in SupT1 and HeLa cells suggests that primary T cells productively infected by HTLV-1 likely also undergo senescence. If so, then how does a virus that induces senescence cause leukemia? How do HTxT cell lines manage to adapt to Tax and continue to divide? To address these questions and to elucidate the pathway by which HTLV-1 infection leads to T cell transformation and ATL, three specific aims are proposed: (1) to delineate the pathway leading from persistent NF-?B activation by Tax to senescence; (2) to investigate the cause and biological effects of HTLV- and Tax-induced chromosome instability; and (3) to elucidate the mechanisms by which cells become adapted to (transformed by) Tax and HTLV-1.
描述(申请人提供):HTLV-I是成人T细胞白血病/淋巴瘤(ATL)的病原体,ATL是一种CD4+T细胞的恶性肿瘤,其病因与病毒反式激活因子/癌蛋白TAX有关。我们已经证明Tax可以激活后期促进复合体/环体(APC/C),这是一种E3泛素连接酶,控制着中期到后期的过渡和有丝分裂的退出。税收激活APC/C导致多泛素化提前,并导致细胞周期蛋白A、细胞周期蛋白B、Securin和Skp2等有丝分裂调节因子降解。Skp2是另一种被称为SCFSkp2的E3泛素连接酶的底物靶向亚基,它介导周期蛋白E/A-CDK2抑制物(CKI)p27的破坏。税收诱导的APC/C对Skp2的降解导致SCFSkp2失活和p27稳定。另一种CKI基因p21的mRNA水平也因启动子的激活和Tax的稳定而急剧增加。P21和p27的大量表达导致细胞衰老,称为税收诱导的快速衰老(Tax-Induced Rapid Fastage,Tax-IRS)。不出所料,HTLV-1感染的HeLa和SupT1 T细胞也停止了衰老。相反,p21和p27缺陷的细胞,如HOS,在HTLV-1感染或Tax表达后逃脱Tax-IRS并继续分裂。然而,它们以多核和DNA非整倍体的形式发展出戏剧性的核异常。重要的是,p27的下调和p21的错误定位在表达Tax的HTLV-1转化的T(HTxT)细胞中很常见,很可能是通过激活PI3K-Akt通路发生的。我们的最新结果表明,在S/G2期间,税收导致了DNA复制许可因子CDT1的显著积累。在一个最令人兴奋的最新发展中,我们发现,税收抑制核因子-βB的激活完全取消了税收-IRS。我们的发现提出了几个重要的问题:持续的NF-B激活是如何导致p21/p27上调和衰老的?核因子?B的激活是否位于APC/C激活和CDT1积聚的上游?税收诱导的CDT1的积累是否导致DNA重新/超复制,它能否解释在Tax表达细胞中所看到的戏剧性的核异常?最后,HTLV-1在SupT1和HeLa细胞中诱导的衰老样停滞表明,感染HTLV-1的原代T细胞可能也经历了衰老。如果是这样,那么导致衰老的病毒是如何导致白血病的呢?HTxT细胞系如何适应税收并继续分裂?为了解决这些问题并阐明HTLV-1感染导致T细胞转化和ATL的途径,人们提出了三个特定的目标:(1)描绘由TAX持续激活的NF-B到衰老的途径;(2)研究HTLV和TAX诱导的染色体不稳定的原因和生物学效应;(3)阐明细胞对TAX和HTLV-1适应的机制。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

CHOU-ZEN GIAM其他文献

CHOU-ZEN GIAM的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('CHOU-ZEN GIAM', 18)}}的其他基金

HTLV-1 Replication/Reactivation-Induced DNA Damage: Mechanisms and Pathogenesis
HTLV-1 复制/重新激活诱导的 DNA 损伤:机制和发病机制
  • 批准号:
    10572907
  • 财政年份:
    2022
  • 资助金额:
    $ 29.87万
  • 项目类别:
Cell Cycle Regulation and Adult T Cell Leukemia
细胞周期调节和成人 T 细胞白血病
  • 批准号:
    8052727
  • 财政年份:
    2010
  • 资助金额:
    $ 29.87万
  • 项目类别:
Cell Cycle Regulation and Adult T Cell Leukemia
细胞周期调节和成人 T 细胞白血病
  • 批准号:
    8607791
  • 财政年份:
    2010
  • 资助金额:
    $ 29.87万
  • 项目类别:
Cell Cycle Regulation and Adult T Cell Leukemia
细胞周期调节和成人 T 细胞白血病
  • 批准号:
    8396677
  • 财政年份:
    2010
  • 资助金额:
    $ 29.87万
  • 项目类别:
Cell Cycle Regulation and Adult T Cell Leukemia
细胞周期调节和成人 T 细胞白血病
  • 批准号:
    7866744
  • 财政年份:
    2010
  • 资助金额:
    $ 29.87万
  • 项目类别:
Cell Cycle Regulation and Adult T Cell Leukemia
细胞周期调节和成人 T 细胞白血病
  • 批准号:
    8448784
  • 财政年份:
    2010
  • 资助金额:
    $ 29.87万
  • 项目类别:
Cell Cycle Regulation and Adult T Cell Leukemia
细胞周期调节和成人 T 细胞白血病
  • 批准号:
    8265753
  • 财政年份:
    2010
  • 资助金额:
    $ 29.87万
  • 项目类别:
Cell Cycle Regulation and Adult T Cell Leukemia
细胞周期调节和成人 T 细胞白血病
  • 批准号:
    8214695
  • 财政年份:
    2010
  • 资助金额:
    $ 29.87万
  • 项目类别:
Cell Cycle Regulation and Adult T Cell Leukemia
细胞周期调节和成人 T 细胞白血病
  • 批准号:
    8791965
  • 财政年份:
    2010
  • 资助金额:
    $ 29.87万
  • 项目类别:
Carl Zeiss LSM 510 Confocal Inverted Microscope System
Carl Zeiss LSM 510 共焦倒置显微镜系统
  • 批准号:
    7389697
  • 财政年份:
    2008
  • 资助金额:
    $ 29.87万
  • 项目类别:

相似海外基金

Pathophysiology of Adult T-cell leukemia/lymphoma
成人 T 细胞白血病/淋巴瘤的病理生理学
  • 批准号:
    10609828
  • 财政年份:
    2022
  • 资助金额:
    $ 29.87万
  • 项目类别:
Inhibition of T-cell Receptor Signaling for Treatment of Adult T-cell Leukemia Lymphoma
抑制 T 细胞受体信号转导治疗成人 T 细胞白血病淋巴瘤
  • 批准号:
    10684172
  • 财政年份:
    2022
  • 资助金额:
    $ 29.87万
  • 项目类别:
Pathophysiology of Adult T-cell leukemia/lymphoma
成人 T 细胞白血病/淋巴瘤的病理生理学
  • 批准号:
    10369933
  • 财政年份:
    2022
  • 资助金额:
    $ 29.87万
  • 项目类别:
Inhibition of T-cell Receptor Signaling for Treatment of Adult T-cell Leukemia Lymphoma
抑制 T 细胞受体信号转导治疗成人 T 细胞白血病淋巴瘤
  • 批准号:
    10518751
  • 财政年份:
    2022
  • 资助金额:
    $ 29.87万
  • 项目类别:
Adoptive immunotherapy for adult T-cell leukemia/lymphoma with ex vivo expanded multi-tumor associated antigen specific cytotoxic T-cells
使用离体扩增的多肿瘤相关抗原特异性细胞毒性 T 细胞对成人 T 细胞白血病/淋巴瘤进行过继免疫治疗
  • 批准号:
    20K17375
  • 财政年份:
    2020
  • 资助金额:
    $ 29.87万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Establishment of a novel drug discovery platform for adult T-cell leukemia/lymphoma using PROTAC technology
利用PROTAC技术建立成人T细胞白血病/淋巴瘤新药发现平台
  • 批准号:
    20K08736
  • 财政年份:
    2020
  • 资助金额:
    $ 29.87万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of a multiplex RT-PCR method to assess the risk of stage progression in adult T-cell leukemia/lymphoma
开发多重 RT-PCR 方法来评估成人 T 细胞白血病/淋巴瘤分期进展的风险
  • 批准号:
    20K07700
  • 财政年份:
    2020
  • 资助金额:
    $ 29.87万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Elucidation of genomic alterations and the clinicopathological significance in adult T-cell leukemia/lymphoma
阐明成人 T 细胞白血病/淋巴瘤的基因组改变及其临床病理学意义
  • 批准号:
    20K16177
  • 财政年份:
    2020
  • 资助金额:
    $ 29.87万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Screening of Promising Chemotherapeutic Candidates from Plants against Human Adult T-Cell Leukemia/Lymphoma
从植物中筛选有前途的抗成人 T 细胞白血病/淋巴瘤的化疗候选药物
  • 批准号:
    19K16403
  • 财政年份:
    2019
  • 资助金额:
    $ 29.87万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
A new diagnostic algorithm using biopsy specimens in adult T-cell leukemia/lymphoma: combination of RNA in situ hybridization and quantitative PCR for HTLV-1
使用成人 T 细胞白血病/淋巴瘤活检标本的新诊断算法:结合 RNA 原位杂交和 HTLV-1 定量 PCR
  • 批准号:
    19K07438
  • 财政年份:
    2019
  • 资助金额:
    $ 29.87万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了